|
**Overview**: Total Protein Panel**Introduction**: The Total Protein Panel is a diagnostic tool designed to assess total protein levels using serum samples. In India, hypoalbuminemia (low total protein/albumin) is common in chronic liver disease, malnutrition, nephrotic syndrome, and inflammation, affecting ~10-20 percent of hospitalized patients and contributing to edema, ascites, or poor wound healing. High morbidity from under-testing in rural/low-SES patients with edema, ascites, or chronic illness, limited labs, delayed nutritional support or disease-specific therapy leading to complications. Per biochemistry practices aligned with ICMR and Indian Journal of Clinical Biochemistry guidelines, the test employs spectrophotometry for total protein, albumin, and globulin over 1-2 days with high accuracy, valuable for evaluating synthetic function and inflammation. This diagnostic falls under protein screening and targets patients with edema, liver/kidney disease, or malnutrition, addressing accurate detection to guide albumin infusion, nutrition, or further workup. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise protein assessment and reducing complications in chronic diseases. Its serum-based approach ensures reliable total protein measurement.**Other Names**: Total Protein Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry, compliant with 2025 standards.**Historical Milestone**: Total protein/albumin standard; in India, routine in liver/kidney clinics.**Purpose**: The test assesses 3 parameters including total protein to guide liver/kidney disorder screening, detect hypo/hyperproteinemia, inform management.**Test Parameters**: 1. Total Protein, 2. Albumin, 3. Globulin.**Pretest Condition**: Fasting 10-12 hours recommended; patients should report edema or chronic illness.**Specimen**: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on liver/kidney symptoms, diet.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected protein abnormality including edema, benefits of screening, and minimal discomfort from venipuncture.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Low total protein/albumin indicates liver/kidney disease or malnutrition, necessitating specialist input.**Specialist Consultation**: Hepatologists or nephrologists should be consulted for management.**Additional Supporting Tests**: LFT, RFT, urine protein for confirmation.**Test Limitations**: Nonspecific; comprehensive approach required.**References**: Indian Journal of Clinical Biochemistry 2024, Protein Studies India 2023. |
